ARM vs AMD vs ALAB Stock Comparison

Arm Holdings, Advanced Micro Devices and Astera Labs Prices as of Oct 23, 2026 Peers: Industry group
ARM Arm Holdings Plc /Uk
$210.33 -36.8% 1M +26.2% 1Y
Market cap
$236.92B
P/E
226.9x
Revenue (TTM)
$5.16B
Div. yield
–
Semiconductor Design Technology
1 win
AMD Advanced Micro Devices Inc
$516.79 -15.9% 1M +119.9% 1Y
Market cap
$867.62B
P/E
134.8x
Revenue (TTM)
$41.31B
Div. yield
–
Semiconductor Design Technology
3 wins
ALAB Astera Labs, Inc.
$257.16 -28.7% 1M +57.1% 1Y
Market cap
$44.74B
P/E
121.1x
Revenue (TTM)
$1.20B
Div. yield
–
Semiconductor Design Technology
4 wins

Head to Head

8 decided of 12

Astera Labs leads on 4 of the 12 questions below (Astera Labs 4, Advanced Micro Devices 3, Arm Holdings 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionARMAMDALABLeader
Larger companyMarket capitalisation $236.92B $867.62B $44.74B AMD
Cheaper on earningsLower P/E, profitable companies only 226.9x 134.8x 121.1x ALAB
Cheaper on forward earningsLower price / next fiscal year consensus EPS 101.1x 70.0x 68.9x ALAB
Faster revenue growthRevenue growth, trailing twelve months +25.1% +39.5% +98.5% ALAB
More profitableNet margin, trailing twelve months 20.2% 15.6% 30.7% ALAB
Better return on capitalReturn on invested capital — 8.0% — –
Less leveragedLower net debt / EBITDA — -1.0x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +26.2% +119.9% +57.1% AMD
Better 5-year returnAnnualised price return, 5 years — +34.0%/yr — –
Less volatileAnnualised volatility, 1 year 78.8% 68.6% 98.4% AMD
Higher overall scoreMean of the five percentile scores vs peers 63/100 59/100 61/100 ARM

Percentile Scorecard

ARMAMDALAB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisARMAMDALAB
Valuation 7 #88 of 95 28 #69 of 95 9 #87 of 95
Growth 88 #12 of 93 96 #5 of 93 91 #9 of 93
Profitability 77 #22 of 91 67 #31 of 91 79 #20 of 91
Financial Health 78 #23 of 102 67 #34 of 102 92 #9 of 102
Shareholder Returns – 39 #47 of 76 35 #50 of 76
Overall 63 59 61
  • ARM ranked among 104 companies in Semiconductors
  • AMD ranked among 104 companies in Semiconductors
  • ALAB ranked among 104 companies in Semiconductors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodARMAMDALABSPY
1 month -36.8%-15.9%-28.7% -1.0%
3 months -19.1%-1.0%-11.8% +2.9%
6 months -10.4%+48.6%+20.8% +6.4%
Year to date +92.4%+141.3%+54.6% +11.4%
1 year +26.2%+119.9%+57.1% +13.1%
3 years +301.6%+408.3%— +79.4%
3 years, per year +59.0%+72.0%— +21.5%
5 years —+331.3%— +67.7%
5 years, per year —+34.0%— +10.9%
10 years —+7,826.2%— +255.2%
10 years, per year —+54.9%— +13.5%

Risk

MeasureARMAMDALABSPY
Volatility, 1Y 78.8%68.6%98.4% 12.7%
Downside volatility, 1Y 71.2%65.6%100.9% 12.7%
Beta vs S&P 500, 1Y 3.453.223.88 1.00
Return / volatility, 1Y 0.331.750.58 1.03
Max drawdown, 5Y -54.0%-65.4%-63.7% -25.4%
From 52-week high -52.1%-20.4%-46.8% -2.5%
52-week high $439.46$649.42$483.02 $779.14
52-week low $104.55$190.95$100.27 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleARMAMDALAB
P/E now vs peer median 213.8xmedian 41.5x 131.1xmedian 41.5x 120.0xmedian 41.5x
P/S now vs peer median 43.3xmedian 6.9x 20.4xmedian 6.9x 37.1xmedian 6.9x
EV/EBITDA now vs peer median 189.4xmedian 27.3x 87.6xmedian 27.3x 151.9xmedian 27.3x
P/FCF now vs peer median 110.9xmedian 35.6x 100.8xmedian 35.6x 161.2xmedian 35.6x
P/B now vs peer median 25.9xmedian 4.2x 12.5xmedian 4.2x 25.9xmedian 4.2x
PEG now vs peer median 6.03median 2.31 0.25median 2.31 —median 2.31

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsARMAMDALAB
Revenue $5.16B $41.31B $1.20B
Gross profit $5.03B $21.98B $903.00M
Operating income $877.00M $6.49B $273.45M
Net income $1.04B $6.43B $369.49M
Free cash flow $2.01B $8.37B $276.68M
R&D $2.96B $9.39B $434.25M
EPS (diluted) $0.98 $3.88 $2.02
Cash & equivalents $3.06B $5.09B $111.45M
Total debt – $12.89B –
Shares (diluted) 1.07B 1.66B 183.34M
Enterprise value $222.63B $824.37B $39.98B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricARMAMDALAB
P/E 213.8x 131.1x 120.0x
P/FCF 110.9x 100.8x 161.2x
P/Operating cash flow 106.6x 83.7x 132.9x
P/S 43.3x 20.4x 37.1x
P/B 25.9x 12.5x 25.9x
P/Tangible book 26.5x 16.3x 25.9x
EV/EBITDA 189.4x 87.6x 151.9x
EV/EBIT 250.0x 128.5x 158.6x
EV/Revenue 42.5x 20.2x 36.1x
EV/FCF 109.0x 99.6x 156.7x
EV/Operating cash flow 104.7x 82.7x 129.2x
PEG (3Y EPS CAGR) 6.03 0.25 –

Growth

14 metrics
MetricARMAMDALAB
Revenue growth (1Y) 25.1% 39.5% 98.5%
Revenue CAGR (3Y) 24.7% 23.6% –
Gross profit growth (1Y) 25.6% 55.9% 97.5%
Gross profit CAGR (3Y) 25.4% 32.0% –
Operating income growth (1Y) 14.9% 186.2% 546.3%
Operating income CAGR (3Y) 21.6% 167.6% –
Net income growth (1Y) 49.4% 127.0% 268.9%
Net income CAGR (3Y) 37.2% 537.7% –
EPS growth (1Y) 48.7% 123.1% 258.4%
EPS CAGR (3Y) 35.5% 533.6% –
Operating cash flow growth (1Y) 105.5% 106.7% 34.8%
Operating cash flow CAGR (3Y) 34.7% 61.4% –
Free cash flow growth (1Y) 121.8% 106.9% 31.5%
Free cash flow CAGR (3Y) 33.3% 64.9% –

Profitability

14 metrics
MetricARMAMDALAB
Gross margin 97.5% 53.2% 75.1%
EBITDA margin 22.5% 23.0% 23.7%
Operating margin 17.0% 15.7% 22.8%
Pretax margin 24.5% 18.3% 26.8%
Net margin 20.2% 15.6% 30.7%
FCF margin 39.0% 20.3% 23.0%
Operating cash flow margin 40.6% 24.4% 27.9%
Return on equity 16.3% 9.8% 23.0%
Return on assets 12.6% 7.8% 20.6%
Return on invested capital – 8.0% –
Return on capital employed 9.0% 9.3% 16.8%
Asset turnover 0.5x 0.5x 0.7x
Cash conversion (OCF / net income) 2.0x 1.6x 0.9x
Stock comp / revenue 22.4% 4.6% 16.2%

Financial Health

11 metrics
MetricARMAMDALAB
Debt / assets – 3.8% –
Debt / equity – 0.0x –
Net debt / EBITDA – -1.0x –
Debt / FCF – 0.4x –
Liabilities / assets 22.9% 20.4% 10.7%
Equity / assets 77.1% 79.6% 89.3%
Interest coverage – 44.1x –
Current ratio 5.3x 2.6x 10.1x
Quick ratio 4.9x 1.7x 8.8x
Cash ratio 3.2x 1.1x 7.6x
Altman Z-score 54.04 30.47 132.26

Shareholder Returns

7 metrics
MetricARMAMDALAB
Dividend yield – – –
Net buyback yield – 0.0% 0.0%
Shareholder yield – 0.0% 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusARMAMDALAB
Forward P/E 101.1xFY2026 70.0xFY2026 68.9xFY2026
EPS, next fiscal year $2.08FY2026 $7.38FY2026 $3.73FY2026
EPS growth, next FY +17.5%FY2026 +77.0%FY2026 +102.7%FY2026
EPS growth, the year after +51.0% +111.8% +64.9%
Revenue, next fiscal year $5.70BFY2026 $53.07BFY2026 $2.01BFY2026
Revenue growth, next FY +15.8%FY2026 +53.2%FY2026 +135.3%FY2026
Revenue growth, the year after +38.5% +60.6% +46.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersARMAMDALAB
Held by institutions 9.3% 72.5% 73.6%
Institutions holding 955 3,991 986
Change in shares held, QoQ +12.4% +10.7% +5.8%
Institutions buying 593 2,270 660
Institutions selling 257 1,456 253
Buyers to sellers 2.31 1.56 2.61

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ARMAMDALAB
ARM 1.00 0.65 0.53
AMD 0.65 1.00 0.63
ALAB 0.53 0.63 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ARM, AMD and ALAB?

Advanced Micro Devices (AMD) is the largest by market capitalisation: Arm Holdings (ARM) $236.92B, Advanced Micro Devices (AMD) $867.62B, Astera Labs (ALAB) $44.74B.

Which stock is cheaper, ARM, AMD and ALAB?

Astera Labs (ALAB) trades on the lowest price-to-earnings ratio (Arm Holdings (ARM) 226.9x, Advanced Micro Devices (AMD) 134.8x, Astera Labs (ALAB) 121.1x). On next year's consensus earnings, Astera Labs (ALAB) is cheapest (Arm Holdings (ARM) 101.1x, Advanced Micro Devices (AMD) 70.0x, Astera Labs (ALAB) 68.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Astera Labs (ALAB) grew revenue fastest over the trailing twelve months: Arm Holdings (ARM) +25.1%, Advanced Micro Devices (AMD) +39.5%, Astera Labs (ALAB) +98.5%.

Which company is more profitable?

Astera Labs (ALAB) has the highest net margin (Arm Holdings (ARM) 20.2%, Advanced Micro Devices (AMD) 15.6%, Astera Labs (ALAB) 30.7%).

Which stock has performed better?

Over the past year Advanced Micro Devices (AMD) returned the most: Arm Holdings (ARM) +26.2%, Advanced Micro Devices (AMD) +119.9%, Astera Labs (ALAB) +57.1%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Advanced Micro Devices (AMD) has been the steadiest (Arm Holdings (ARM) 78.8%, Advanced Micro Devices (AMD) 68.6%, Astera Labs (ALAB) 98.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ARM, AMD and ALAB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Astera Labs (ALAB) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.